Dr. Kevin Manohar Salis presented on computational models in research. He discussed how preclinical studies are used to test new drugs before human administration by studying effects, pharmacokinetics, pharmacodynamics, and refining methods. He categorized drugs proposed for COVID-19 into gene-gene networks, expression-based algorithms, and docking simulations for small molecules and monoclonal antibodies. References discussed computer-aided drug design applications to COVID-19 and using artificial intelligence for COVID-19 drug discovery and vaccine development.